Often in routine tests, Complete Blood Count or Heamogram is tested which gives an indication if an individual is suffering from Anaemia. Anaemia is a less understood condition by the masses and involves a battery of tests to reveal the underlying condition. Anaemia could either be due to nutritional deficiencies, abnormal red blood cells or any other conditions like liver or kidney disorder that could lead to iron deficiency. Tests like TIBC and Transferrin (which is one of the many tests in serum iron studies) is used to assess iron deficiency or overload. Total iron-binding capacity (TIBC) is a medical laboratory test that measures the blood’s capacity to bind iron with transferrin. It is performed by drawing blood and measuring the maximum amount of iron that it can carry, which indirectly measures transferrin since transferrin is the most dynamic carrier.
TIBC is usually ordered along with other iron tests when the doctor suspects iron deficiency or overload. One or more tests may be ordered when there are signs of anaemia, especially when a CBC is performed and shows red blood cells that are microcytic and hypochromic and the haemoglobin and haematocrit levels are low.
Signs and symptoms of Iron Deficiency include fatigue, tiredness that is often severe and chronic (which does not go away despite enough rest), dizziness, weakness, instances of black out, headache, pale skin.
In cases where there are Iron Overload, it tends to worsen over a period of time since Iron tends to get accumulated in cells and tissues. Symptoms include joint pain, fatigue, weakness, weight loss, lack of energy, abdominal pain, hair loss etc.
Iron and TIBC are also ordered when there is a case of suspected iron poisoning. This is most common in children who accidentally overdose with vitamins or other supplements containing iron.
Lack of proteins in the diet also leads to Anaemia and hence doctors usually order tests like Pre-albumin to evaluate a person’s nutritional status.
Often Iron Studies are done in combination and as profiles (battery of 3-4 tests) that give the exact cause of the condition.
Global & National Quality Accreditations – CAP (USA) and NABL , Govt. of India.
Guaranteed error free diagnosis.
Bar Coded and automated process. No room for manual errors.
Specific normal range for Indian population built from 33 years of experience.
Sample collection from home/office.
Metropolis: Experience + Expertise
Over the past 3 decades we have earned the respect of doctors and patients. Today we conduct over 30 million tests annually with accuracy each year. Our repertoire extends over 4500 tests and over 100 different technologies. Our customer care is available round the clock for any queries that you may have.
Save tax on the Preventive health check-ups up to Rs. 5000, under section 80D of Income Tax Act, 1961
We are Metropolis - Your Pathology Specialist
Metropolis is one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). With operations across India, Africa, South Asia and Middle East.
Our globally accredited clinical laboratories deliver accurate and timely test results. We offer a comprehensive range of clinical laboratory tests and profiles which are used in prediction, early detection, diagnostic screening, confirmation and monitoring of diseases.
Delivering diagnostic services since 1980
Network of 100+ clinical labs & 1100+ patient touch points
Qualified team of phlebotomists for Home collection services
Certified NABL and CAP accredited labs
Wide range of 4000+ tests & profiles
Convenience of home collection service
Metropolis Healthcare Limited is proposing subject to applicable statutory or regulatory requirements, receipt of requisite approvals, market conditions and other considerations to undertake an initial public offering of its equity shares and has filed a draft red herring prospectus dated September 27, 2018 (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of the SEBI at www.sebi.gov.in, BSE Limited at www.bseindia.com, National Stock Exchange of India Limited at www.nseindia.com and the websites of Book Running Lead Managers at www.jmfl.com, www.credit-suisse.com, www.investmentbank.kotak.com, www.hdfcbank.com and www.goldmansachs.com. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to same, please refer to the DRHP including the section “Risk Factors” of the DRHP. Potential investors should not rely on the DRHP filed with the SEBI for making any investment decision.